Content for healthcare professionals only

View all Platforms Vascular

Topics Content Type Videos Articles Broadcasts Education Podcasts News Faculty Events Radcliffe Events All Events Resource Hubs Deep Vein Thrombosis

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

LINC 2023: Late-breaking Science Video Collection

Published: 20 June 2023

Views:
1028
Likes:
7

Views:
1028
Likes:
7
Share:

Now Playing
Part 1 | Session 7 of 9
MOTIV Bioresorbable Scaffold in BTK Lesions
Michel Bosiers

Up Next
6m 6s

Part 1 | Session 8 Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK
Marc Sirvent
8m 56s

Part 1 | Session 9 LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions
Sahil Parikh

5m 2s

Part 1 | Session 1 AVPAS: Lutonix AV Post-Approval Study Scott O Trerotola

5m 18s

Part 1 | Session 2 The ELEGANCE Registry: Ranger DCB In Under-Represented Groups Marianne Brodmann

4m 51s

Part 1 | Session 3 RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety Marianne Brodmann

4m 48s

Part 1 | Session 4 IN.PACT AV ACCESS: Outcomes to Date Matteo Tozzi

8m 14s

Part 1 | Session 5 TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes Koen Deloose

7m 13s

Part 1 | Session 6 POPCORN Registry: DCB Treatment for Peripheral Artery Disease Yoshimitsu Soga

Average (ratings)

No ratings

Your rating

Overview

Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

Expert Interviews

Short, accessible Expert Interviews with select faculty focusing on the results, applicability, and impact on future research.

9 sessions
AVPAS: Lutonix AV Post-Approval Study	Watch now
The ELEGANCE Registry: Ranger DCB In Under-Represented Groups	Watch now
RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety	Watch now
IN.PACT AV ACCESS: Outcomes to Date	Watch now
TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes	Watch now
POPCORN Registry: DCB Treatment for Peripheral Artery Disease	Watch now
MOTIV Bioresorbable Scaffold in BTK Lesions	Watch now
Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK	Watch now
LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions	Watch now

About the episode

LINC 23 - We are joined by Dr Michel Bosiers (Inselspital Bern, CH) to discuss the findings of the MOTIV BTS BTK trial, which studied the immediate and long-term clinical outcomes of the MOTIV™ Bioresorbable Scaffold in patients with peripheral artery disease and/or critical limb ischemia.

The MOTIV™ scaffold is a novel device made from Tyrocore™, with thin struts to promote vessel healing and maintain radial strength. 60 patients were enrolled in the trial who were followed up to 36 months after implantation of the MOTIV™ device. Data revealed at LINC 2023 shows a 99% technical success rate and an 88.3% rate of vessel patency.

Questions:

What was the objective of this trial?
Tell us more about the MOTIV Scaffold, and its unique features.
What was the patient population and study design?
What was the key data released at LINC 2023?
How should the findings of this trial impact both future research and clinical practice?

Recorded remotely from Bern, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent

Faculty Biographies

Michel Bosiers

Michel Bosiers

Senior Consultant

Dr Michel Bosiers is the Senior Consultant at the University Hospital Bern. He is co-founder of Vascupedia. His areas of interest include vascular innovation, peripheral vascular disease and endovascular access.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.